Background: Traditionally the right ventricular (RV) pacing lead is placed in the RV
120-130 ms. [2] [3] [4] Successful CRT has also been associated with significant reduction in morbidity and mortality. 5 Recently, several retrospective and prospective studies have also suggested similar benefits in patients with NYHA functional class I and II heart failure. 6, 7 The presence of left ventricular dyssynchrony as manifest by left bundle branch block (LBBB) is common in heart failure 8 and is associated with a better outcome and LV reverse remodeling after CRT. 9, 10 However, a significant proportion of heart failure patients do not respond to CRT. 11 Although response to CRT is at least partly dependent upon left ventricular lead location, other factors may play a significant role. One of these factors is right ventricular (RV) lead placement. Although the RV lead is commonly placed at or near the apex; septal, outflow tract and para-hisian sites (nontraditional) have also been used with RV pacing leads. These nontraditional pacing sites in the right ventricle have been postulated to simulate a more physiologic electrical activation of the heart, to reduce ventricular dyssynchrony and to potentially obtain more favorable hemodynamics. 12 The RV septum, RV outflow tract, RV midseptum have been used as alternatives to RV apical pacing. [13] [14] [15] The impact of alternate RV lead position on the outcome of CRT is largely unknown. Studies comparing RV apical with alternative site RV pacing have found conflicting evidence. To understand this issue
further, we performed a meta-analysis on this subject.
2 | ME TH ODS
| Data sources and search strategy
This review was constructed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for systematic reviews and meta-analyses. 16 We searched Medline/ PubMed, Embase, Scopus, and the Cochrane Library for publications. to the computer search, we manually reviewed the reference list of all included studies and published reviews to complete the search.
The search strategy, study selection, and meta-analysis were guided by a written protocol. Two investigators (SPS and KD) independently performed the database search and agreed on the final study selection.
| Inclusion and exclusion criteria
We included studies that met all of the following criteria (i) randomized controlled studies comparing RV apical pacing with nonapical sites in right ventricle (septum, midseptum, RV outflow tract) for CRT; (ii)a report of at least one of the outcomes of interest (All-cause mortality, composite of all-cause mortality or heart failure hospitalization, change in EF, change in left ventricu- 
| Major outcomes
The primary endpoints of our meta-analysis were all-cause mortality and a composite of all-cause mortality and heart failure hospitalizations. Secondary endpoints were echocardiographic measures of reverse ventricular remodeling (change in EF, LVESV, and LVEDV and >15% improvement EF), and adverse events related to RV lead placement, including arrhythmias.
| Statistical analysis
The meta-analysis was performed using a random effects model with We used the Cochrane Collaborations' tool for assessing risk of bias in the individual studies.
| Quality assessment
We used the Cochrane Collaboration tool for assessing risk of bias to determine the quality of included randomized controlled trials (RCTs). This tool assesses the risk of selection bias, performance bias, detection bias, attrition bias, reporting bias, and other biases.
Each RCT is categorized on the basis of criteria determining the likelihood of potential threats to validity. Quality assessment was independently performed by 2 reviewers (SPS and KD).
3 | RESULTS
| Description of individual studies
We retrieved 82 citations from electronic database and manual searches as shown in Figure 1 . We reviewed 16 citations for fulltext articles; 7 full-text articles were included in the final analysis. [17] [18] [19] [20] [21] [22] [23] Four of the included studies were post hoc analyses of the RCTs [19] [20] [21] [22] and one was randomized crossover trial. 21 All the included studies were published between 2011 and 2016. There were a total of 1641 patients included in our meta-analysis. A total of 1199 patients had apical lead placement while 492 had nonapical placement (midseptum, high septum, RV outflow tract, and RV free wall).
The study by Miranda et al 23 were variable across the studies. The average age of study patients was 66 years and males comprised of more than 75% of the total population. Details of the included studies and baseline characteristics of patients are summarized in Table 1 . The details about pooled outcomes and adverse events are summarized in Table 2 .
| Primary outcomes
There was no difference in all-cause mortality between apical and nonapical RV lead placement (5% vs 4.3%, OR = 0.86; 95% CI: 0.45-1.64; P = .65; I 2 = 11%) ( Figure 2 ). We did not find a significant difference in the composite of death or heart failure hospitalization between 2 groups (14.2% vs 12.9%, OR = 0.92; 95% CI: 0.61-1.38; P = .68; I 2 = 0) ( Figure 2 ).
| Secondary outcomes 3.3.1 | Change in EF, LVEDV, and LVESV
No difference in improvement in EF was noted between apical and nonapical group (Weighted mean difference = 0.37; 95% CI: À2.75-3.48; P = .82; I 2 = 68%) ( Figure 3 ).
There was no difference in LVEDV between apical and nonapical (WMD = 3.67; 95% CI: À4.86-12.20; P = .40; I 2 = 89%) group as shown in (Figure 3 ). Because of significant heterogeneity in change in EF and LVEDV, sensitivity analysis was performed by excluding 1 study at a time to evaluate the effect of any individual study in the overall heterogeneity. We found that the Miranda et al study 23 contributed to significant heterogeneity in both our endpoints. However, even after removal of this study, there was no significant difference in the weighted mean between the 2 groups. Similarly, no difference was noted in change of LVESV between apical and nonapical groups (WMD = À1.20; 95% CI: À4.32-1.91; P = .45; I 2 = 0) ( Figure 3 ).
| Number of patients with >15% improvement in LVESV
The proportion of patients who achieved >15% improvement in LVESV was no different between the apical and nonapical groups (OR = 0.85; 95% CI: 0.62-1.16; P = .31; I 2 = 0) (Figure 4 ).
| Adverse events
Only 2 studies 19, 20 reported on the occurrence of ventricular arrhythmias. It was more common in nonapical group but was not statistically significant (16% vs 20%; P = .7). Only a few studies reported on the RV lead-related complications. RV lead complication rates were low and similar between 2 groups (0.5% vs 0.6%) ( Table 2 ).
| Sensitivity analysis
We performed the sensitivity analyses by assessing the contribution of each study to the overall estimate from the pooled estimate and by excluding individual study one at a time and recalculating the pooled odds ratio for the remaining. It did not substantially change the pooled point estimate on any endpoints.
As prespecified in our methodology, we performed meta-analysis using random effect model. However, as there was extremely low heterogeneity in primary outcomes, we also analyzed data using fixed-effect model. Final results did not differ between 2 models for all the outcomes.
F I G U R E 2
Forest plot of all-cause mortality and composite of all-cause mortality and heart failure hospitalization Mortality data were similar between the 2 groups in all studies except for the study by Asbach et al where all mortality was seen in the apical pacing group. Patients in the midseptal group were younger (66.2 AE 9.5 years vs 69.4 AE 10.1 years, P = .042) and more likely to be male (80% vs 60%, P = .048) in this study. It is arguable that since in this study, a significantly greater number of younger patients were in the midseptal group, mortality was lower. An earlier study had hypothesized that the elderly would not benefit as much from CRT as the younger patients. 26 However, this effect might have been balanced by the proportion of men in the midseptal group, who have in general been found to have a lower benefit with CRT-ICD in MADIT-CRT trial compared with women. 27 In the study by Asbach et al, both apical and nonapical groups had a similar extent of reverse remodeling; therefore the mechanism which may have promoted heart failure and death in apical group remains unclear. In general, the finding of no significant change in mortality rates between different RV lead positions is in keeping up with the result of an observational study that used mortality and morbidity as endpoints. An observational study that is not based on MES-guided electrode placement had also found midseptal RV lead position to be associated with greater improvement in left ventricular end-diastolic diameter. 31 In the study, patients from both groups showed similar improvement in functional NYHA class and improvement in LVEDV was mostly seen in subgroup of dilated cardiomyopathy patients.
A recently published Danish registry study found nonapical RV lead position in CRT to be associated with improved outcome of death and heart failure hospitalization in patients with nonischemic heart disease only. 32 It has been suggested that optimal RV lead location may be tai- Reverse remodeling and improvement in left ventricular function are postulated to occur over a period of 3-6 months, but the improvement in left ventricular function beyond a year has been described, and the included studies do not address this.
| LIMITATIONS
Our meta-analysis has several limitations. A shorter and variable duration of follow-up, inherent weakness of using data from post hoc analysis of RCTs and crossover trial, smaller sample sizes in the nonapical group, small number of primary events are some important shortcomings in the included studies. Studies are also limited by use of fluoroscopy alone for lead placement evaluation, but this likely reflects clinical practice well. Absence of details on LV lead position relative to RV for determining clinical outcomes is other major limitation.
| CONCLUSION
This meta-analysis shows that nonapical RV pacing in CRT is not associated with improvement in clinical and echocardiographic endpoints compared with apical RV pacing. Our conclusion is drawn from small number of events noted in the included studies with short follow-up. So, further studies with longer follow-up might be needed to provide strong evidentiary base to draw firm conclusion.
Further studies should focus on detailed analysis of the LV with RV apical and nonapical lead locations based on MES and confirmation of lead location by cardiac CT.
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